List of proposals

Priority in Vaccination for Autistic Individuals through Mobile Application
Key Proposal Details

Development of the mobile application and collection of data will be done over a 6-month period

Funding Requirement (INR)

14,66,000

Name of the Institute/Incubator

IIT BHU

Geography of the technology - National or any particular States for implementation 

NA (proposal seems localized to only the Varanasi district)

Name of the PI/Faculty/Researcher/Technologist/Startup

Dr. A.R. Jac Fredo

Current Status of Proposal

Submitted to potential donors

Click here for more details

Development and Manufacturing of ‘InstaCOVID nAb’: A Rapid Diagnostic Test Kit for determination of Post-Vaccination Effectiveness for COVID-19
Key Proposal Details

1. Development and standardization of protocol for InstaCOVID nAb, for determination of presence of neutralizing antibodies in COVID-19 vaccinated population

2. ICMR validation of InstaCOVID nAb test kit protocol

3. Manufacturing the highly sensitive InstaCOVID nAb test kit at scale and distribute it on a pan-India level

4. Support will be needed to engage government agencies, regulators and state governments

5. Project duration: 10 months

Funding Requirement (INR)

47,00,000

Name of the Institute/Incubator

IIT Bombay

Geography of the technology - National or any particular States for implementation 

Maharashtra, and later to other states

Name of the PI/Faculty/Researcher/Technologist/Startup

Rashmi Tambe

Current Status of Proposal

Exploratory conversation scheduled

Click here for more details

Drug Discovery against COVID-19: Exploration of New Chemical Spaces to Identify New Drugs against SARS-CoV2
Key Proposal Details

Use NCBS's strength and expertise in cell biology, infection assays and plant biology to develop and perform high-throughput drug screens to identify novel chemical molecules that will be effective against SARS-Cov2 and have the potential for rapid development to clinics

Proposal aims to use two different approaches for drug discovery against SARS-Cov2:

  1. High throughput screen of drug-like molecules in SARS-Cov2 infection assays

  2. Screen a set of natural products for anti-Covid19 effects 

Funding Requirement (INR)

87,90,000

Name of the Institute/Incubator

NCBS Bangalore

Geography of the technology - National or any particular States for implementation 

Pan-India and globally

Name of the PI/Faculty/Researcher/Technologist/Startup

Varadharajan Sundaramurthy

Current Status of Proposal

Under review

Click here for more details

Request for Funding for Development and Clinical Trials of a Recombinant, Protein Subunit Vaccine for COVID-19
Key Proposal Details

IISc and Mynvax have jointly developed and patented a novel thermotolerant vaccine based on the RBD of the SARS-CoV-2 Spike Glycoprotein. The vaccine candidate has been shown to be tolerant to transient exposure to very high temperature ( 100°C) and can be stored at 37°C for over a month without losing its shape. It is now commonly referred to as the ‘warm vaccine’

Funding Requirement (INR)

7,25,00,000

Name of the Institute/Incubator

IISc Bangalore and Mynvax

Geography of the technology - National or any particular States for implementation 

Pan-India and globally

Name of the PI/Faculty/Researcher/Technologist/Startup

Gautham Nadig

Current Status of Proposal

Under review